Vicinitas Therapeutics

Manufacturing · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

442 Littlefield Ave, South San Francisco...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1

About Vicinitas Therapeutics

Based in San Francisco, CA, Vicinitas Therapeutics is a biotechnology company with a focus on cancer and genetic disorders.Explore more
Vicinitas Therapeutics's Social MediaPopular SearchesVicinitas TherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Vicinitas Therapeutics Org Chart

PhoneEmail
EF
United States flag for contact location.

Director

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Vicinitas Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Vicinitas Therapeutics

Compare insights from companies similar to Vicinitas Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Vicinitas Therapeutics

<$5M
11-50
Private
$65M
2017
$7.8M
11-50
Private
$101M
2021
PC
Pia Challita-EidChief Scientific Officer
$5.5M
11-50
Private
$50M
2021
Peng Yue, Co-Founder & Chief Executive Officer at ReviR Therapeutics
Peng YueCo-Founder & CEO
$5.3M
11-50
Private
-
2018
N/A
<$5M
11-50
Private
$78M
-
<$5M
11-50
Private
$65M
2018
<$5M
1-10
Private
$123.3M
2017
Guy DiPierro, Chief Operating Officer & Founder at Indapta Therapeutics
Guy DiPierroChief Operating Officer & Founder
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Vicinitas Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Vicinitas Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vicinitas Therapeutics.

Vicinitas Therapeutics financials insights

Gather financial insights about Vicinitas Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2022

Series A

$65M

See All Vicinitas Therapeutics's Financials Insights

Vicinitas Therapeutics Tech Stack

A closer look at the technologies used by Vicinitas Therapeutics

Most Recent Scoops

Open Position
Promotion
Executive Move
Executive Moves, Promotion
Open Position
New Hire
Executive Move
Board of Directors
Funding
See more scoops

Vicinitas Therapeutics News & Media

  • Vicinitas Therapeutics Appoints Adam Hughes as Chief Scientific Officer

    SOUTH SAN FRANCISCO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel therapeutics for cancer and genetic disorders, today announced the appointment of Adam Hughes, Ph.D., as Chief Scientific Officer. Dr. Hughes previously served as VP of Medicinal Chemistry at Vicinitas.
  • Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as Chief Executive Officer

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel therapeutics in cancer and genetic disorders, today announced that Christian Hofmann, Ph.D., has been appointed as the company’s Chief Executive Officer and member of the board of directors. “Since the launch of Vicinitas less than a year ago, we have made important progress in advancing our proprietary Deubiquitinase Targ
Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Vicinitas Therapeutics

What is Vicinitas Therapeutics's official website?
Vicinitas Therapeutics's official website is www.vicinitastx.com
What is Vicinitas Therapeutics's Revenue?
Vicinitas Therapeutics's revenue is <$5 Million
What is Vicinitas Therapeutics's SIC code?
Vicinitas Therapeutics's SIC: 28,283
What is Vicinitas Therapeutics's NAICS code?
Vicinitas Therapeutics's NAICS: 32,325
How many employees does Vicinitas Therapeutics have?
Vicinitas Therapeutics has 11-50 employees
What industry does Vicinitas Therapeutics belong to?
Vicinitas Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Vicinitas Therapeutics competition?
Vicinitas Therapeutics top competitors include: Rezo Therapeutics, ReviR Therapeutics, D2G Oncology, Adcentrx Therapeutics
What technology does Vicinitas Therapeutics use?
Some of the popular technologies that Vicinitas Therapeutics uses are: reCAPTCHA, ClearCompany, Eploy, Engage ATS
What does Vicinitas Therapeutics do?

Based in San Francisco, CA, Vicinitas Therapeutics is a biotechnology company with a focus on cancer and genetic disorders.... Read More

What are Vicinitas Therapeutics social media links?
Vicinitas Therapeutics Linkedin page
Is Vicinitas Therapeutics a public company?
Vicinitas Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Vicinitas Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.